MedTrace Logo

A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures

NCT00643136 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2008-04-24

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of pregabalin on sleep problems in patients with seizures.

Conditions

  • Sleep Deprivation
  • Epilepsies, Partial

Interventions

DRUG

Pregabalin

Pregabalin capsules 75 mg twice daily on Days 1-4, then 150 mg twice daily on Days 5-28

DRUG

Placebo

Matching placebo capsules twice daily for 28 days

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-11-30
Completion
2004-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00643136 on ClinicalTrials.gov